Evaluation of neutrophil–lymphocyte ratio, platelet–lymphocyte ratio and red blood cell distribution width–platelet ratio as early predictor of acute pancreatitis in pregnancy

Abstract

NLR might be used as an early marker of AP and may have a role in prediction of disease severity.

Utility of complete blood count parameters to detect premature ovarian insufficiency in cases with oligomenorrhea/amenorrhea

“…Ilhan and colleagues used NLR, PLR, and RPR as diagnostic markers in POI cases and found that only NLR was statistically significant to diagnose POI. As a result of their studies, NLR was proposed as a new marker in POI as an easily accessible marker that is cheaper than AMH . In a study conducted by Yildirim and colleagues, the relationship between POI and NLR, CRP, serum amyloid A protein (SAA) was investigated.…”

Association between platelet to lymphocyte ratio, plateletcrit and the presence and severity of hyperemesis gravidarum

“…The NLR has been investigated as a parameter of inflammation in numerous diseases in obstetrics and gynecology practice . The NLR was evaluated as an early predictor of acute pancreatitis, and it was shown to have significant predictivity for pancreatitis in pregnancy . Endometriosis and preterm labor, other inflammation‐related conditions, have also been associated with increased NLR levels …”

Evaluation of the prognostic value of platelet to lymphocyte ratio in patients with hepatocellular carcinoma

“…In the meta-analysis of patients with colorectal cancer, Huang et al included 17 studies and concluded that elevated PLR was associated with poor overall survival, disease-free survival, as well as higher cancer stage and poor differentiation (7). Recently, the utility of PLR has also been extensively explored in various non-cancerous populations, including patients with acute coronary syndrome, immunoglobulin-resistant Kawasaki disease, premature ovarian insufficiency and acute pancreatitis (24)(25)(26)(27). These associations were also attributed to the role of PLR as a systemic inflammation marker.…”